查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886521

生物樣本庫設備市場－全球產業規模、佔有率、趨勢、機會和預測，依產品、應用（再生醫學、藥物研發及其他）、地區和競爭格局分類，2020-2030年預測

Biobank Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application (Regenerative Medicine, Drug Discovery, and Others), By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球生物樣本庫設備市場規模為499.7億美元，預計2030年將以5.80%的複合年成長率成長至700.8億美元。生物樣本庫設備涵蓋了生物樣本全面管理（包括採集、處理、儲存和檢索）所需的專用儀器和系統。此類別通常包括超低溫冰箱、自動化液體處理設備和先進的樣本管理軟體。

市場概覽
預測期 2026-2030
市場規模：2024年 499.7億美元
市場規模：2030年 700.8億美元
複合年成長率：2025-2030年 5.80%
成長最快的細分市場 藥物發現
最大的市場 北美洲

主要市場促進因素

對個人化和精準醫療日益成長的需求是全球生物樣本庫設備市場的主要驅動力。這種醫療模式根據患者的個別特徵量身定做治療方案，需要收集大量且種類豐富的優質生物樣本。

主要市場挑戰

建立和維護現代化生物樣本庫設施所需的大量初始資本投資，對全球生物樣本庫設備市場的成長構成了顯著挑戰。建造一流的生物樣本庫需要大量的資金用於購買專用儀器、先進的低溫儲存系統和複雜的樣本管理軟體。

主要市場趨勢

人工智慧和機器學習技術在生物樣本庫設備中的應用，正在建構智慧系統，從而提升營運效率和預測能力。這些演算法最佳化了樣本追蹤，確保了精準的品質控制，並促進了複雜的資料分析，直接提高了生物樣本的完整性和科研利用率。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球生物樣本庫設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品分類（設備（低溫儲存系統、警報監控系統、其他）、介質和耗材）
    • 依應用領域（再生醫學、藥物研發、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美生物樣本庫設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生物樣本庫設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太生物樣本庫設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲生物樣本庫設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲生物樣本庫設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球生物樣本庫設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Hamilton Company
  • Merck KgaA
  • Lonza Group AG
  • QIAGEN NV
  • Stemcell Technologies Inc.
  • Tecan Group AG
  • Thermo Fisher Scientific Inc

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23280

The Global Biobank Equipment Market, valued at USD 49.97 Billion in 2024, is projected to experience a CAGR of 5.80% to reach USD 70.08 Billion by 2030. Biobank equipment encompasses specialized instruments and systems essential for the comprehensive management of biological samples, including collection, processing, storage, and retrieval. This category typically includes ultra-low temperature freezers, automated liquid handlers, and advanced sample management software.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 49.97 Billion
Market Size 2030USD 70.08 Billion
CAGR 2025-20305.80%
Fastest Growing SegmentDrug Discovery
Largest MarketNorth America

Key Market Drivers

The increasing demand for personalized and precision medicine is a principal driver for the global biobank equipment market. This paradigm tailors medical treatments to individual patient characteristics, requiring extensive and diverse collections of high-quality biological samples. Biobanks provide these essential repositories, facilitating genomic sequencing, biomarker discovery, and targeted therapy development. The need for precise sample collection, processing, and long-term preservation directly elevates demand for specialized equipment, including advanced freezers and automated aliquotting systems.

Key Market Challenges

The substantial initial capital investment required for establishing and maintaining modern biobank facilities represents a notable challenge to the growth of the Global Biobank Equipment Market. Developing a state-of-the-art biobank necessitates significant financial resources for acquiring specialized instruments, advanced cryogenic storage systems, and sophisticated sample management software. This high upfront cost creates a considerable barrier for numerous entities, including smaller research institutions and emerging biotechnology companies, that may lack the extensive budgets needed to initiate or upgrade their biobanking operations.

Key Market Trends

AI and machine learning integration in biobank equipment is enabling intelligent systems for enhanced operational efficiency and predictive capabilities. These algorithms optimize sample tracking, ensure precise quality control, and facilitate complex data analysis, directly improving biospecimen integrity and utility for research. This advancement allows biobanks to manage extensive datasets, uncover subtle patterns, and accelerate biomarker discovery.

Key Market Players

  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Hamilton Company
  • Merck KgaA
  • Lonza Group AG
  • QIAGEN N.V.
  • Stemcell Technologies Inc.
  • Tecan Group AG
  • Thermo Fisher Scientific Inc

Report Scope:

In this report, the Global Biobank Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biobank Equipment Market, By Product:

  • Equipment (Cryogenic Storage System, Alarm Monitoring Systems, Others)
  • Media & Consumables

Biobank Equipment Market, By Application:

  • Regenerative Medicine
  • Drug Discovery
  • Others

Biobank Equipment Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biobank Equipment Market.

Available Customizations:

Global Biobank Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biobank Equipment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Equipment (Cryogenic Storage System, Alarm Monitoring Systems, Others), Media & Consumables)
    • 5.2.2. By Application (Regenerative Medicine, Drug Discovery, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Biobank Equipment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biobank Equipment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Biobank Equipment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Biobank Equipment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Biobank Equipment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biobank Equipment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. France Biobank Equipment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Biobank Equipment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Biobank Equipment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Biobank Equipment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia Pacific Biobank Equipment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Biobank Equipment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India Biobank Equipment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Biobank Equipment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Biobank Equipment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Biobank Equipment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. Middle East & Africa Biobank Equipment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Biobank Equipment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Biobank Equipment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Biobank Equipment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. South America Biobank Equipment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biobank Equipment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Biobank Equipment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Biobank Equipment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Biobank Equipment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton, Dickinson and Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Bio-Techne Corporation
  • 15.3. Hamilton Company
  • 15.4. Merck KgaA
  • 15.5. Lonza Group AG
  • 15.6. QIAGEN N.V.
  • 15.7. Stemcell Technologies Inc.
  • 15.8. Tecan Group AG
  • 15.9. Thermo Fisher Scientific Inc

16. Strategic Recommendations

17. About Us & Disclaimer